AHR and atrial fibrillation: CH223191 is a bona fide AhR antagonist, unlike αNF, which can be competitively excluded by stronger agonists and antagonists.60 Like the AHRKO cells, MCF-7 cell migration was promoted rather than inhibited in the presence of CH223191, with the greatest shift observed at 100 nM AF (Fig. 5F).